Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$394K Buy
2,709
+3
+0.1% +$415 0.26% 79
2026
Q2
$348K Buy
2,706
+15
+0.6% +$1.76K 0.24% 89
2026
Q1
$324K Sell
2,691
-10
-0.4% -$1.15K 0.27% 83
2025
Q4
$284K Buy
+2,701
New +$254K 0.23% 89

Other funds holding MRK

JM2 Capital's MRK Position: Q3 2026 in Review

JM2 Capital increased its Merck (MRK) stake by 0.11% in Q3 2026, buying an estimated $415 and bringing the position to 2,709 shares worth $394K. The position accounts for 0.26% of the portfolio, ranked #79.

JM2 Capital first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • JM2 Capital held 2,709 shares of Merck worth $394K as of Q3 2026.
  • JM2 Capital bought 3 Merck shares in Q3 2026, an estimated $415.
  • Merck made up 0.26% of JM2 Capital's portfolio in Q3 2026, its #79 holding.
  • JM2 Capital first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on JM2 Capital's 13F filing for Q3 2026, filed 14 Oct 2026.